Market Overview:
The global bioinformatics in IVD testing market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth of this market can be attributed to the increasing demand for personalized medicine, growing prevalence of chronic diseases, and technological advancements in bioinformatics tools and platforms. The global bioinformatics in IVD testing market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into hardware and software. The hardware segment dominates the global bioinformatics in IVD testing market owing to its wide applicability across various segments such as genomics research laboratories, hospitals & clinics, pharmaceutical companies & CROs etc., whereas software forms a smaller but faster-growing sub-segment due to its advantages such as low cost and easy implementation compared with hardware solutions. On the basis of application, cardiovascular diseases account for majority share followed by diabetes mellitus (DM), cancer (carcinoma), chronic obstructive pulmonary disease (COPD) etc.
Product Definition:
Bioinformatics is a field of biology that utilizes computer science and information technology to develop methods and software tools for the management, analysis, interpretation and visualization of large biological data sets. The application of bioinformatics in the field of IVD testing helps to improve accuracy and efficiency while reducing cost.
Hardware:
Hardware is the part of bioinformatics that includes computer systems and related accessories. The hardware used in bioinformatics for IVD testing can be divided into two parts, namely input devices and output devices. The input device consists of scanners, sequencers, PCR machines etc., while the output device comprises storage devices like hard drives, memory sticks etc.
Software:
Software is the collection of tools and techniques that are used to carry out a specific task or series of tasks. In bioinformatics, software is used for storing and processing biological data. It helps in organizing information so that it can be easily retrieved when needed.
Application Insights:
The chronic diseases segment dominated the market in 2017 and is expected to witness significant growth over the forecast period. The rising prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases is anticipated to drive the demand for bioinformatics in IVD testing. Moreover, an increase in research activities pertaining to these disorders coupled with a rise in government initiatives that promote early diagnosis is further anticipated to boost industry growth.
The others segment includes neurological disorders as well as genetic disease testing. Increasing adoption of bioinformatics for population screening has led to reduced waiting times for diagnosis compared with conventional methods used by doctors¢â‚¬â„¢ offices or hospitals due its abilityto detect abnormalities at an early stage which leads into effective treatment at a lower cost associated with it.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, increased adoption rate of advanced technologies, and high healthcare expenditure in this region. Moreover, increasing demand for cost-effective & rapid diagnostic solutions is expected to propel regional growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income levels and growing target population base in emerging economies such as India & China & Indonesia etc., Rising awareness about early diagnosis coupled with government initiatives are some factors driving regional growth.
Growth Factors:
- Increasing demand for personalized medicine
- Advances in sequencing and bioinformatics technology
- Growth of the genomics market
- Proliferation of next-generation sequencing (NGS) platforms and applications
- Increased use of big data analytics in life sciences
Scope Of The Report
Report Attributes
Report Details
Report Title
Bioinformatics in IVD Testing Market Research Report
By Type
Hardware, Software
By Application
Cardiovascular Diseases, Chronic Diseases, Diabetes, Cancer, Others
By Companies
Affymetrix, AssureRx Health Inc., Aperico Technologies Inc., Biodesix Inc., Bioreference Laboratories Inc., CardioDx Inc., Datech Oncology, Life Technologies, Pathogenica, Medtronic Inc., Signal genetics, One Lambda Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
223
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Bioinformatics in IVD Testing Market Report Segments:
The global Bioinformatics in IVD Testing market is segmented on the basis of:
Types
Hardware, Software
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular Diseases, Chronic Diseases, Diabetes, Cancer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Affymetrix
- AssureRx Health Inc.
- Aperico Technologies Inc.
- Biodesix Inc.
- Bioreference Laboratories Inc.
- CardioDx Inc.
- Datech Oncology
- Life Technologies, Pathogenica
- Medtronic Inc.
- Signal genetics
- One Lambda Inc.
Highlights of The Bioinformatics in IVD Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hardware
- Software
- By Application:
- Cardiovascular Diseases
- Chronic Diseases
- Diabetes
- Cancer
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bioinformatics in IVD Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bioinformatics is the application of computer science and engineering principles to the analysis of biological data. Bioinformatics can be used to identify patterns in large sets of genomic or proteomic data, to generate hypotheses about how genes or proteins function, and to develop tools for analyzing that data.
Some of the major players in the bioinformatics in ivd testing market are Affymetrix, AssureRx Health Inc., Aperico Technologies Inc., Biodesix Inc., Bioreference Laboratories Inc., CardioDx Inc., Datech Oncology, Life Technologies, Pathogenica, Medtronic Inc., Signal genetics, One Lambda Inc..
The bioinformatics in ivd testing market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bioinformatics in IVD Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bioinformatics in IVD Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bioinformatics in IVD Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bioinformatics in IVD Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bioinformatics in IVD Testing Market Size & Forecast, 2018-2028
4.5.1 Bioinformatics in IVD Testing Market Size and Y-o-Y Growth
4.5.2 Bioinformatics in IVD Testing Market Absolute $ Opportunity
Chapter 5 Global Bioinformatics in IVD Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bioinformatics in IVD Testing Market Size Forecast by Type
5.2.1 Hardware
5.2.2 Software
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bioinformatics in IVD Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bioinformatics in IVD Testing Market Size Forecast by Applications
6.2.1 Cardiovascular Diseases
6.2.2 Chronic Diseases
6.2.3 Diabetes
6.2.4 Cancer
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bioinformatics in IVD Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bioinformatics in IVD Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bioinformatics in IVD Testing Analysis and Forecast
9.1 Introduction
9.2 North America Bioinformatics in IVD Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bioinformatics in IVD Testing Market Size Forecast by Type
9.6.1 Hardware
9.6.2 Software
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bioinformatics in IVD Testing Market Size Forecast by Applications
9.10.1 Cardiovascular Diseases
9.10.2 Chronic Diseases
9.10.3 Diabetes
9.10.4 Cancer
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bioinformatics in IVD Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Bioinformatics in IVD Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bioinformatics in IVD Testing Market Size Forecast by Type
10.6.1 Hardware
10.6.2 Software
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bioinformatics in IVD Testing Market Size Forecast by Applications
10.10.1 Cardiovascular Diseases
10.10.2 Chronic Diseases
10.10.3 Diabetes
10.10.4 Cancer
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bioinformatics in IVD Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bioinformatics in IVD Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bioinformatics in IVD Testing Market Size Forecast by Type
11.6.1 Hardware
11.6.2 Software
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bioinformatics in IVD Testing Market Size Forecast by Applications
11.10.1 Cardiovascular Diseases
11.10.2 Chronic Diseases
11.10.3 Diabetes
11.10.4 Cancer
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bioinformatics in IVD Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Bioinformatics in IVD Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bioinformatics in IVD Testing Market Size Forecast by Type
12.6.1 Hardware
12.6.2 Software
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bioinformatics in IVD Testing Market Size Forecast by Applications
12.10.1 Cardiovascular Diseases
12.10.2 Chronic Diseases
12.10.3 Diabetes
12.10.4 Cancer
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bioinformatics in IVD Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bioinformatics in IVD Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bioinformatics in IVD Testing Market Size Forecast by Type
13.6.1 Hardware
13.6.2 Software
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bioinformatics in IVD Testing Market Size Forecast by Applications
13.10.1 Cardiovascular Diseases
13.10.2 Chronic Diseases
13.10.3 Diabetes
13.10.4 Cancer
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bioinformatics in IVD Testing Market: Competitive Dashboard
14.2 Global Bioinformatics in IVD Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Affymetrix
14.3.2 AssureRx Health Inc.
14.3.3 Aperico Technologies Inc.
14.3.4 Biodesix Inc.
14.3.5 Bioreference Laboratories Inc.
14.3.6 CardioDx Inc.
14.3.7 Datech Oncology
14.3.8 Life Technologies, Pathogenica
14.3.9 Medtronic Inc.
14.3.10 Signal genetics
14.3.11 One Lambda Inc.
